Male users and pill format driving growth in GLP-1 use

Man taking pills from box
Men and the pill format of GLP-1s are driving growth in users. (Image: Getty/Abdullah Durmaz)

New data shows both a shift in demographic and the rising popularity of the GLP-1 pill

The GLP-1 pill format is making its mark among users, now accounting for more than one in ten GLP-1 users in Great Britain. And it’s driving rapid growth – the number of British households with at least one GLP-1 user was 8.5% in August, up from 6.3% just six months earlier, according to a new Worldpanel by Numerator report.

“When we began tracking GLP-1 use back in 2024, manufacturers and retailers were always asking us, is this here to stay? Should we really be concerned?” says Nishita Pattni, senior consultant at Worldpanel by Numerator. “Fast forward two years and there has been such a boom. In the last six months, we have seen such an increase in users, as much as it took a year to increase previously.”

The arrival of the GLP-1 pill is very recent and the UK led the way in Europe – the Wegovy pill was approved in the UK in June, the first pill to be approved in Europe. The UK was also first to approve Eli Lilly’s Foundayo (orforglipron) in August. It’s therefore a good indicator of the effect of the pill as it launches across Europe.

“When the pill format was launched this summer, we saw a huge spike, so a lot of these users are first-time users,” says Pattni. “And we saw similar spikes in the US. We only anticipate that it will grow further when we go back into the field in February, when the pill will have been around for over six months.”

Number of male users almost double

Men are also driving growth – they now account for 32% of users, up from 23% in February. That equates to a near doubling in number at 830,000, up from 440,000.

Explore related questions

What accounts for this? “We’ve called this latest report The Evolution Continues, and the appeal and adoption of these drugs is becoming far more mass and widespread,” says Pattni. “To date, the adoption of GLP-1 drugs is not even with 68% of users being female, but the growth that has recently come in has been driven by men, which points to that mass adoption.”

We also see that a chunk of lapsers are returning to GLP-1s, she adds, so the growth is not linear. “It’s still an evolving space, but every time we track this, that appeal is widening and that’s where I think the men come in.”

The rise in men is a space to watch for manufacturers as they may well bring different purchasing patterns and needs.

A £1bn impact but a surprise success story

The impact on grocery spend is now over £1bn (€1.20bn), up from £780m in June, with impulse and indulgence purchases taking the biggest hit. Crisps spend, for example, has fallen 15%. Alcohol is also suffering – spend among GLP-1 users has fallen 15% more than in non-user households.

The overall drop equates to £389 a year displaced from user households’ shopping baskets.

Convenient formats continue to do well and frozen ready meals saw a 30% uplift in volume. However, there was a surprise success story. Hot chocolate and malt drinks were up 22% in spend and 16% in volume.

“It was one of the most surprising growth categories for us,” says Pattni. Along with being a permissible, more lightweight treat, there are a few different theories behind it, she says. “Firstly, we know that users have less disposable income since starting on GLP-1s and hot chocolate and malt drinks are an affordable, accessible treat. Secondly, some users report heightened sensitivity to stimulants, and we’ve seen the likes of energy drinks and instant coffee struggling. Hot chocolate feels like a treat but it’s not overly stimulating.”

More growth is on the horizon

“We were not surprised by the acceleration in users and the drop in spend,” says Pattni. “We’ve been trying to tell everyone that this is here to stay and we are very confident that this will only grow.”

Worldpanel forecasts that GLP-1 usage is set to surpass 10% of Great Britain’s households in 2027. “A lot of our forecast is based on users remaining satisfied, considerers gaining confidence, and various events all falling into place,” says Pattni, “but even our most conservative estimates place it above 10%.”